Evidence map›Paper›PMID 38015956›Full record

ArticleDatabase : the journal of biological databases and curation2023

Overview of DrugProt task at BioCreative VII: data and methods for large-scale text mining and knowledge graph generation of heterogenous chemical-protein relations.

Antonio Miranda-Escalada, Farrokh Mehryary, Jouni Luoma, Darryl Estrada-Zavala, Luis Gasco, Sampo Pyysalo, Alfonso Valencia, Martin Krallinger

Abstract read
In one paragraph

Article in Database : the journal of biological databases and curation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. LSD600: the first corpus of biomedical abstracts annotated with lifestyle-disease relations.Database : the journal of biological databases and curation · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. The overview of the BioRED (Biomedical Relation Extraction Dataset) track at BioCreative VIII.Database : the journal of biological databases and curation · 2024
    Article
  15. Towards discovery: an end-to-end system for uncovering novel biomedical relations.Database : the journal of biological databases and curation · 2024
    Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Antonio Miranda-EscaladaLife Sciences Department, Barcelona Supercomputing Center, Barcelona 08034, Spain.ORCID 0000-0002-5654-001X
Farrokh MehryaryTurkuNLP Group, Department of Computing, University of Turku, Turku 20014, Finland.ORCID 0000-0002-5555-2828
Jouni LuomaTurkuNLP Group, Department of Computing, University of Turku, Turku 20014, Finland.
Darryl Estrada-ZavalaLife Sciences Department, Barcelona Supercomputing Center, Barcelona 08034, Spain.
Luis GascoLife Sciences Department, Barcelona Supercomputing Center, Barcelona 08034, Spain.ORCID 0000-0002-4976-9879
Sampo PyysaloTurkuNLP Group, Department of Computing, University of Turku, Turku 20014, Finland.
Alfonso ValenciaLife Sciences Department, Barcelona Supercomputing Center, Barcelona 08034, Spain.
Martin KrallingerLife Sciences Department, Barcelona Supercomputing Center, Barcelona 08034, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is getting increasingly challenging to efficiently exploit drug-related information described in the growing amount of scientific literature. Indeed, for drug-gene/protein interactions, the challenge is even bigger, considering the scattered information sources and types of interactions. However, their systematic, large-scale exploitation is key for developing tools, impacting knowledge fields as diverse as drug design or metabolic pathway research. Previous efforts in the extraction of drug-gene/protein interactions from the literature did not address these scalability and granularity issues. To tackle them, we have organized the DrugProt track at BioCreative VII. In the context of the track, we have released the DrugProt Gold Standard corpus, a collection of 5000 PubMed abstracts, manually annotated with granular drug-gene/protein interactions. We have proposed a novel large-scale track to evaluate the capacity of natural language processing systems to scale to the range of millions of documents, and generate with their predictions a silver standard knowledge graph of 53 993 602 nodes and 19 367 406 edges. Its use exceeds the shared task and points toward pharmacological and biological applications such as drug discovery or continuous database curation. Finally, we have created a persistent evaluation scenario on CodaLab to continuously evaluate new relation extraction systems that may arise. Thirty teams from four continents, which involved 110 people, sent 107 submission runs for the Main DrugProt track, and nine teams submitted 21 runs for the Large Scale DrugProt track. Most participants implemented deep learning approaches based on pretrained transformer-like language models (LMs) such as BERT or BioBERT, reaching precision and recall values as high as 0.9167 and 0.9542 for some relation types. Finally, some initial explorations of the applicability of the knowledge graph have shown its potential to explore the chemical-protein relations described in the literature, or chemical compound-enzyme interactions. Database URL:  https://doi.org/10.5281/zenodo.4955410.

Indexed as

Data MiningPattern Recognition, AutomatedDatabases, FactualHumansProteinsProteins

Identifiers

PMID38015956
PMCPMC10683943

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.